ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 8–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
November 2025
Fusion Science and Technology
Latest News
NRC cancels advanced reactor meeting due to government shutdown
The Nuclear Regulatory Commission has announced it is cancelling an upcoming advanced reactor stakeholder meeting, originally scheduled for November 19, due to the government shutdown and the limitations on staffing at the agency.
Greg Staack, Yung-Sung Cheng, Yue Zhou, Tom LaBone
Fusion Science and Technology | Volume 71 | Number 4 | May 2017 | Pages 570-574
Technical Note | doi.org/10.1080/15361055.2017.1291041
Articles are hosted by Taylor and Francis Online.
Samples of tritiated LaNi4.15Al0.85 (LANA.85) and 13X zeolite were analyzed to obtain particle size distributions and tritium evolution rates in a simulated lung environment. This information was used to calculate intake-to-dose conversion factors (DCFs), which estimate the committed effective dose (CED) a worker would receive after inhaling either tritiated particulate. The DCFs for tritiated LANA.85 and 13X particulate with a default activity mean aerodynamic diameter (AMAD) of 5 μm were determined to be 1.01E-11 Sv/Bq and 1.11E-11 Sv/Bq, respectively. These results are comparable to that of HTO, 1.8E-11 Sv/Bq, indicating that urine bioassay results can conservatively estimate the dose delivered if the worker was exposed to any mixture of HTO, LANA.85, or 13X.
